Published in Telemedicine Week, April 5th, 2005
This transaction strengthens Molecular Devices' leadership position as a provider of tools for both imaging and G-protein coupled receptor (GPCR) assays, two of the most important and fastest-growing areas of drug discovery.
Transfluor technology, comprising proprietary assays that operate on imaging platforms such as Molecular Devices' Discovery-1 and ImageXpress systems, offers a robust way to visualize key cellular events...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.